These soluble Tau oligomers co-localize with activated microglial cells and reactive astrocytes, observed in both mouse models of Tauopathy and AD/frontotemporal lobar dementia (FTLD) patients’ brains [32]. This evidence concerns the gene MAPT and Alzheimer disease.